Literature DB >> 8083693

Development of the superior temporal neocortex is anomalous in trisomy 21.

J A Golden1, B T Hyman.   

Abstract

Trisomy 21 (Down syndrome) is the most common inherited form of mental retardation in the United States, however, the basis of impaired cognition is unknown. We have used recently developed stereological cell counting techniques to quantitatively examine the pattern of neuronal migration and maturation in one neocortical area during gestation in normal development and in trisomy 21. Normal development of the cerebral cortex occurs in two general sequences: Beginning at approximately 7-8 weeks gestation, migration of cells destined to become neurons results in the accumulation of cells in the cortical mantle. This process is largely complete by 20-21 weeks. Over the next 7-10 weeks an "inside-out" differentiation into lamina of different neuronal densities occurs. Our data suggest that the second phase of cortical development, the emergence of lamination, is both delayed and disorganized in trisomy 21. The observed pattern of cortical maturation may reflect an abnormality in axonal and dendritic arborization that subsequently subserve the connectional and functional units underlying normal cognition.

Entities:  

Mesh:

Year:  1994        PMID: 8083693     DOI: 10.1097/00005072-199409000-00011

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  62 in total

Review 1.  Trisomy 21 and early brain development.

Authors:  Tarik F Haydar; Roger H Reeves
Journal:  Trends Neurosci       Date:  2011-12-09       Impact factor: 13.837

2.  DYRK1A overexpression enhances STAT activity and astrogliogenesis in a Down syndrome mouse model.

Authors:  Nobuhiro Kurabayashi; Minh Dang Nguyen; Kamon Sanada
Journal:  EMBO Rep       Date:  2015-09-15       Impact factor: 8.807

3.  Quantitative MRI Analyses of Regional Brain Growth in Living Fetuses with Down Syndrome.

Authors:  Tomo Tarui; Kiho Im; Neel Madan; Rajeevi Madankumar; Brian G Skotko; Allie Schwartz; Christianne Sharr; Steven J Ralston; Rie Kitano; Shizuko Akiyama; Hyuk Jin Yun; Ellen Grant; Diana W Bianchi
Journal:  Cereb Cortex       Date:  2020-01-10       Impact factor: 5.357

4.  DSCAM/PAK1 pathway suppression reverses neurogenesis deficits in iPSC-derived cerebral organoids from patients with Down syndrome.

Authors:  Xiao-Yan Tang; Lei Xu; Jingshen Wang; Yuan Hong; Yuanyuan Wang; Qian Zhu; Da Wang; Xin-Yue Zhang; Chun-Yue Liu; Kai-Heng Fang; Xiao Han; Shihua Wang; Xin Wang; Min Xu; Anita Bhattacharyya; Xing Guo; Mingyan Lin; Yan Liu
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 14.808

5.  Down syndrome is accompanied by significantly reduced cortical grey-white matter tissue contrast.

Authors:  Anke Bletsch; Caroline Mann; Derek S Andrews; Eileen Daly; Giles M Y Tan; Declan G M Murphy; Christine Ecker
Journal:  Hum Brain Mapp       Date:  2018-06-08       Impact factor: 5.038

6.  Down Syndrome Developmental Brain Transcriptome Reveals Defective Oligodendrocyte Differentiation and Myelination.

Authors:  Jose Luis Olmos-Serrano; Hyo Jung Kang; William A Tyler; John C Silbereis; Feng Cheng; Ying Zhu; Mihovil Pletikos; Lucija Jankovic-Rapan; Nathan P Cramer; Zygmunt Galdzicki; Joseph Goodliffe; Alan Peters; Claire Sethares; Ivana Delalle; Jeffrey A Golden; Tarik F Haydar; Nenad Sestan
Journal:  Neuron       Date:  2016-02-25       Impact factor: 17.173

7.  OLIG2 over-expression impairs proliferation of human Down syndrome neural progenitors.

Authors:  Jie Lu; Gewei Lian; Hui Zhou; Giuseppe Esposito; Luca Steardo; Laurent C Delli-Bovi; Jonathan L Hecht; Q Richard Lu; Volney Sheen
Journal:  Hum Mol Genet       Date:  2012-02-17       Impact factor: 6.150

8.  Consequences of trisomy 16 for mouse brain development: corticogenesis in a model of Down syndrome.

Authors:  T F Haydar; M E Blue; M E Molliver; B K Krueger; P J Yarowsky
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

9.  Gene network disruptions and neurogenesis defects in the adult Ts1Cje mouse model of Down syndrome.

Authors:  Chelsee A Hewitt; King-Hwa Ling; Tobias D Merson; Ken M Simpson; Matthew E Ritchie; Sarah L King; Melanie A Pritchard; Gordon K Smyth; Tim Thomas; Hamish S Scott; Anne K Voss
Journal:  PLoS One       Date:  2010-07-16       Impact factor: 3.240

10.  Deficits in human trisomy 21 iPSCs and neurons.

Authors:  Jason P Weick; Dustie L Held; George F Bonadurer; Matthew E Doers; Yan Liu; Chelsie Maguire; Aaron Clark; Joshua A Knackert; Katharine Molinarolo; Michael Musser; Lin Yao; Yingnan Yin; Jianfeng Lu; Xiaoqing Zhang; Su-Chun Zhang; Anita Bhattacharyya
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.